Showing results (751-760 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor AntagonistsAbel Crespo, Abdelaziz El Maatougui, Pierfrancesco Biagini, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Validation of Reactivity Descriptors to Assess the Aromatic Stacking within the Tyrosine Gate of FimHGoedele Roos, Adinda Wellens, Mohamed Touaibia, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Preparative microfluidic electrosynthesis of drug metabolitesRomain Stalder, Gregory P Roth
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung CancerGiulia Nesi, Simona Sestito, Valentina Mey, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin SecretionFabrizio Giordanetto, Jefferson D Revell, Laurent Knerr, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase InhibitorsMatthew T Burger, Wooseok Han, Jiong Lan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester ModificationsLouise Albertsen, Julie J Andersen, Johan F Paulsson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β InhibitorsHongyi Yu, Michael L Moore, Karl Erhard, et al.
Pageof 438